Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Saudi Med J ; 45(4): 433-436, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38657978

ABSTRACT

Echinococcosis is a parasitic infection that is distributed worldwide. Its clinical presentation depends on the size and location of the cyst. A 7-year-old was found with a superimposed infected pulmonary hydatid cyst that was initially misdiagnosed as complicated pneumonia. Our case underscores the challenges of diagnosing and managing echinococcosis, emphasizes the need for a high index of suspicion, and describes the disease's ability to mimic other clinical entities.


Subject(s)
Echinococcosis, Pulmonary , Humans , Echinococcosis, Pulmonary/diagnosis , Echinococcosis, Pulmonary/diagnostic imaging , Child , Male , Diagnosis, Differential , Tomography, X-Ray Computed
2.
Int J Pediatr Adolesc Med ; 8(4): 229-235, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34401447

ABSTRACT

BACKGROUND AND OBJECTIVE: Peritoneal dialysis (PD) associated peritonitis is the most common cause of morbidity, mortality, and treatment failure in patients undergoing PD. We aimed to identify the incidence, pathogens, antibiotic susceptibility, and the outcome of peritoneal dialysis (PD)-associated peritonitis in children. METHODS: Data from medical records of children who underwent PD between 2007 and 2018 in King Fahad Medical City were retrospectively collected. All children aged <14 years undergoing chronic PD were included. The demographic characteristics of patients, peritonitis rates, and clinical outcomes were collected. RESULTS: In total, 131 children [boys, 68 (51.9%)] underwent automated PD for 305 years. The most common age group was 6-12 years (61 patients, 46.6%). A total of 74.0% of patients were new to dialysis; 25.2% were transferred from hemodialysis. Peritonitis incidence was 0.6 episodes/patient-year. Gram-positive and -negative organisms were identified in 50.1% and 22% episodes, respectively, whereas cultures remained negative in 20.5% episodes. Coagulase-negative Staphylococcus was the most common isolated organism (22.1%), followed by methicillin-sensitive S. aureus (11.1%). Peritonitis was resolved in 153 (73.6%) episodes, whereas 52 (25.0%) episodes required removal through the catheter. The multivariate logistic regression analysis found the exit site infection to be a risk factor for catheter removal. Three (1.4%) episodes caused death due to peritonitis complicated by septic shock . CONCLUSIONS: Our data showed that the most common organisms causing peritonitis were similar to those reported in the previous international registry. The rate of peritonitis was high, but markedly improved in the past two years.

3.
J Infect Public Health ; 12(5): 666-672, 2019.
Article in English | MEDLINE | ID: mdl-30992228

ABSTRACT

AIM: To identify the risk factors, laboratory profile, microbial profile, mortality and complications, mortality causing organisms and antimicrobial susceptibility patterns of neonatal sepsis at a tertiary care hospital. METHODS: A retrospective study was conducted using the neonatal intensive care unit (NICU) database in King Fahad Medical City (KFMC), Riyadh, Saudi Arabia. All neonates born in KFMC with clinically diagnosed sepsis in the NICU were included in this study. RESULTS: During the study period, a total of 245 neonates with a culture-proven diagnosis of neonatal sepsis were included in this study and 298 episodes of sepsis were observed. Out of the 298 episodes, EOS occurred 33 (11.1%) times, and LOS occurred 265 (88.9%) times. For both neonates with EOS and LOS prematurity was the major neonatal risk factors for sepsis 16 (48.5%), 214 (80.8%); respectively. Multiparty and delivery by caesarean section were the top maternal risk factors of both EOS and LOS. Nneonates with LOS had high CRP, Total WBC count and thrombocytopenia compared to EOS neonates. Our results showed that in the EOS neonates, GBS was the most common pathogen followed by Escherichia Coli. In LOS neonates, the common organisms were Staphylococcus spp., Klebsiella and Pseudomonas aeruginosa. Mortality rate of neonatal sepsis is higher in EOS 5 (15.2%) from total EOS compared to LOS 24 (11.3%) from total LOS. All Gram-negative bacteria were sensitive to Amikacin. Gram-negative non-fermenting bacteria, such as P. aeruginosa and Acinetobacter were sensitive to amikacin and gentamycin. All Gram-positive bacteria were sensitive to gentamycin. Among thirteen Candida albicans isolates, 85% were sensitive to fluconazole. CONCLUSION: Concerted efforts are needed to determine the spectrum of risk factors and the clinical characteristics of EOS and LOS in order to implement appropriate treatment strategies as sepsis remains to be a serious danger to neonatal wellbeing. Moreover, our study emphasizes that use of aminoglycosides is much agreeable as compared to the broad spectrum antibiotics which are more rampantly used nowadays.


Subject(s)
Anti-Bacterial Agents/pharmacology , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Intensive Care Units, Neonatal , Neonatal Sepsis/epidemiology , Neonatal Sepsis/microbiology , Anti-Bacterial Agents/therapeutic use , Birth Weight , Female , Humans , Infant, Newborn , Male , Microbial Sensitivity Tests , Neonatal Sepsis/mortality , Retrospective Studies , Risk Factors , Saudi Arabia/epidemiology , Tertiary Care Centers/statistics & numerical data
4.
Saudi Med J ; 40(3): 252-259, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30834420

ABSTRACT

OBJECTIVES: To describe and interpret local antibiograms from a single tertiary care center to monitor the trends of antimicrobial resistance (AMR) patterns and establish baseline data for further surveillance. Methods: We performed a retrospective descriptive review of antibiograms data between January 2010 and December 2015 from King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia. Results: A total of 51,491 isolates were identified, and most were gram-negative (76.2%). Escherichia coli was the most frequently isolated organism (36.8%), followed by Coagulase-negative Staphylococcus (28.4%) and Staphylococcus aureus (27.5%). The detection of antibiotic-resistant organisms, especially extended-spectrum beta-lactamase-producing Escherichia coli (31%-41%), increased over time. The sensitivity of Streptococcus pneumoniae to penicillin improved from 66% to 100% (p less than 0.001). Gram-negative isolates had excellent overall susceptibility to amikacin, variable susceptibility to piperacillin-tazobactam and carbapenems, and declining susceptibility to ceftazidime, ciprofloxacin, and cefepime. Conclusion: Streptococcus pneumoniae susceptibility to penicillin significantly improved over time, which might be because of the introduction of the pneumococcal vaccine. Conversely, the upward trend in resistant gram-negative organisms is worrisome and warrants the implementation of antimicrobial stewardship programs.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Gram-Negative Bacteria/drug effects , Staphylococcus/drug effects , Streptococcus pneumoniae/drug effects , Acinetobacter baumannii/drug effects , Coagulase/metabolism , Escherichia coli/drug effects , Escherichia coli/enzymology , Hospitals , Klebsiella pneumoniae/drug effects , Microbial Sensitivity Tests , Penicillin Resistance , Pseudomonas aeruginosa/drug effects , Retrospective Studies , Saudi Arabia , Staphylococcus/enzymology , Vancomycin-Resistant Enterococci/drug effects , beta-Lactamases/metabolism
5.
Int J Pediatr Adolesc Med ; 5(3): 122-126, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30805546

ABSTRACT

BACKGROUND: Anaerobic meningitis is mainly caused by Bacteroides fragilis and it is rarely detected in children. Few cases have been reported and there is usually an underlying cause. The timing of early recognition is crucial because any delay in the diagnosis and initiation of appropriate antimicrobial therapy has a devastating outcome. Only 14 cases have been reported in 50 years. To the best of our knowledge, the present case is the first to be reported in Saudi Arabia with no underlying etiology. CASE PRESENTATION: We describe a 35-day-old male infant with culture-negative pyogenic meningitis who did not show satisfactory response to the empirical antibiotics, consequently, he developed severe subdural/epidural empyema and ventriculitis. When the drained empyema was cultured anaerobically, B. fragilis was detected and the patient improved after treatment with metronidazole combined with adjuvant surgical drainage of the empyema, and he finally had hydrocephalus. No underlying etiology was found to explain his infection. CONCLUSION: B. fragilis is an uncommon cause of meningitis that requires a high index of clinical suspicion. Any pyogenic cerebrospinal fluid with negative culture should draw the attention of physicians to an unusual organisms such as anaerobes because early identification and initiation of appropriate antimicrobials can prevent long-term morbidity and mortality.

6.
Saudi Med J ; 38(10): 1034-1037, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28917068

ABSTRACT

OBJECTIVES: To identify clinical presentation, predisposing factors, and the outcome in patients with Group A Streptococcal bacteremia. Methods: This is a retrospective study of 33 pediatric and adult patients with Streptococcus pyogenes bacteremia, admitted at King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia from 2007 to 2015. Results: Thirty-three patient records, documenting bacteremia with group A beta-hemolytic streptococcus, were reviewed. Approximately 51.5% were pediatric and 48.5% were adult patients, with a male to female ratio of 2:1. The most frequently reported complications were renal impairment (45.5%) and acute respiratory distress (21.2%), followed by localized infection (15.2%), pleural effusion (6.1%), abscess (9.1%), necrotizing fasciitis (9.1%), septic arthritis, and osteomyelitis (3%). There were 10 episodes of shock: 6 were in pediatric and 4 were in adult patients. At the end of the study period, 12.1% patients died from the illness, 81.1% recovered from illness with no sequelae, while 6.1% recovered with sequelae. Mortality was observed in 4 patients; of them, 3 were pediatric patients and one was an adult with co-morbidities. Conclusions: We have noted a minimal change in the disease pattern over the 28 years in Saudi Arabia. The management of invasive GAS infection depends on an accurate and timely diagnosis with an appropriate use of antimicrobial therapy. The highest risks appear to be related to chronic illness. Invasive Group A Streptococcal infection is known to have a high mortality rate.


Subject(s)
Bacteremia/epidemiology , Streptococcal Infections/epidemiology , Streptococcus pyogenes , Abscess/epidemiology , Adolescent , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/epidemiology , Bacteremia/drug therapy , Bacteremia/microbiology , Bacteremia/mortality , Child , Child, Preschool , Fasciitis, Necrotizing/epidemiology , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Mortality , Osteomyelitis/epidemiology , Pleural Effusion/epidemiology , Renal Insufficiency/epidemiology , Respiratory Distress Syndrome/epidemiology , Retrospective Studies , Risk Factors , Saudi Arabia/epidemiology , Shock, Septic/epidemiology , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Streptococcal Infections/mortality , Young Adult
7.
Saudi Med J ; 34(10): 1068-72, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24145943

ABSTRACT

Basidiobolomycosis is a rare fungal infection caused by basidiobolus ranarum. The vast majority of gastrointestinal basidiobolomycosis cases were reported from tropical and subtropical regions. We report a Saudi pediatric patient with ileal basidiobolomycosis and initial clinical presentation mimicking acute appendicitis before being misdiagnosed as Crohn's disease. Our case is the first to report effective treatment of pediatric gastrointestinal basidiobolomycosis using voriconazole mono-therapy. In addition, we present extensive review of pediatric gastrointestinal basidiobolomycosis in medical literature.


Subject(s)
Antifungal Agents/therapeutic use , Crohn Disease/diagnosis , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Zygomycosis/diagnosis , Child, Preschool , Crohn Disease/drug therapy , Crohn Disease/physiopathology , Diagnosis, Differential , Humans , Male , Voriconazole , Zygomycosis/drug therapy , Zygomycosis/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...